CN Stock MarketDetailed Quotes

603590 Beijing Konruns Pharmaceutical

Watchlist
  • 25.39
  • -0.09-0.35%
Market Closed Dec 20 15:00 CST
4.06BMarket Cap35.41P/E (TTM)

Beijing Konruns Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beijing Konruns Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.283B--
--2024/FY-- / 1.077B--
--2023/FY920.012M / 1.049B--
--2022/FY866.726M / 877.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.283B--
--2024/FY-- / 1.077B--
--2023/FY920.012M / 1.049B--
--2022/FY866.726M / 877.000M--
--------

Unlock Free Earnings Estimates

Beijing Konruns Pharmaceutical Earnings Reports

  • Kangchen Pharmaceutical\'s 2024 Third Quarter Report

    Oct 29 12:00 ET

  • Kangchen Pharmaceutical 2024 Semi-Annual Report

    Aug 27 12:00 ET

  • Summary of Kangchen Pharmaceutical\'s 2024 Semi-Annual Report

    Aug 27 12:00 ET

  • Kangchen Pharmaceutical's Announcement on Corrections to the 2023 Annual Report and Annual Report Summary

    May 5 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    Zhejiang Lanyu Digital Technology
    301585
    73.00 +204.80%
    BBK Test Systems
    301598
    83.98 +118.36%
    MEIZHIGAO
    834765
    29.18 +29.98%
    Youkeshu Technology
    300209
    5.75 +20.04%
    Hangzhou Raycloud Technology Co.,Ltd
    688365
    13.90 +20.03%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Dec 22, 2024

    Strong Buy

    • Strong Buy

      88.89%

    • Buy

      11.11%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Specialized, Special and New
    Specialized, Special and New
    Intraday+2.45%
    Civil-military Integration
    Civil-military Integration
    Intraday+1.03%